Patent classifications
A61B5/42
UPPER GASTROINTESTINAL BLEEDING MONITORING SYSTEM
An upper gastrointestinal bleeding monitoring system includes a detection device and a signal processing device to determine bleeding condition of an upper gastrointestinal tract by using relation of time and intensity ratios of RGB three primary colors. The detecting device is placed to the upper gastrointestinal tract of a patient via his/her mouth or nasal passage and then stay the upper gastrointestinal tract for several days for detection of bleeding. The signal processing device may receive and display signal from the detection device to help medical professionals check if bleeding occurs in an upper gastrointestinal tract. Moreover, a procedure of determination of bleeding in an upper gastrointestinal tract with the upper gastrointestinal bleeding monitoring system is described.
METHODS AND SYSTEMS FOR ACOUSTIC DATA TRANSMISSION
A method of communicating with an ingestible capsule includes detecting the location of the ingestible capsule, focusing a multi-sensor acoustic array on the ingestible capsule, and communicating an acoustic information exchange with the ingestible capsule via the multi-sensor acoustic array. The ingestible capsule includes a sensor that receives a stimulus inside the gastrointestinal tract of an animal, a bidirectional acoustic information communications module that transmits an acoustic information signal containing information from the sensor, and an acoustically transmissive encapsulation that substantially encloses the sensor and communications module, wherein the acoustically transmissive encapsulation is of ingestible size. The multi-sensor array includes a plurality of acoustic transducers that receive an acoustic signal from a movable device, and a plurality of delays, wherein each delay is coupled to a corresponding acoustic transducer. Each delay may be adjusted according to a phase of a signal received by the corresponding acoustic transducer.
Automatic treatment of pain
Disclosed are methods and medical device systems for automated delivery of therapies for pain and determination of need for and safety of treatment. In one embodiment, such a medical device system may comprise a sensor configured to sense at least one body signal from a patient; and a medical device configured to receive a first sensed body signal from the sensor; determine a patient pain index based at least in part on said first sensed body signal; determine whether said patient pain index is above at least a first pain index threshold; determine a safety index based at least in part on a second sensed body signal; select a pain treatment regimen based on at least one of said safety index and or a determination that said pain index is above said first pain index threshold; and deliver said pain treatment regimen.
Devices for testing distal colonic and anorectal function
A pellet for testing distal colonic and anorectal function. In one embodiment the pellet comprises a bag comprising the exterior of the pellet wherein the bag is comprised of a polymer that is reactive with a catalyst to form a more solid-like substance. In another embodiment, the pellet may comprise one of a grapheme layer, a wavelength transducer, or a magnetically attractive element. In another embodiment the pellet may comprise a telescopic extender and further comprise a telescope bad coupled to the telescopic extender.
Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract
The present disclosure relates to methods of collecting and testing bacteria containing samples from within the gastrointestinal (GI) tract of a subject. The methods may include disposing an ingestible device in the GI tract, collecting a bacteria-containing sample from the GI tract, selectively lysing eukaryotic cells in the sample by combining the sample with a dried reagent, exposing bacteria in the sample to resazurin in the ingestible device to produce resorufin, emitting light from the ingestible device, the emitted light being filtered through an optical filter to control for scatter so that the light interacts with the resorufin to produce fluorescence, and measuring a total fluorescence from the resorufin; or a rate of change of fluorescence from the resorufin as a function of time within the GI tract of the subject; and correlating the measured parameter to a number of viable bacterial cells in the sample.
Flexible piezoelectric devices for gastrointestinal motility sensing
Improvements in ingestible electronics with the capacity to sense physiologic and pathophysiologic states have transformed the standard of care for patients. Yet despite advances in device development, significant risks associated with solid, non-flexible gastrointestinal transiting systems remain. Here, we disclose an ingestible, flexible piezoelectric device that senses mechanical deformation within the gastric cavity. We demonstrate the capabilities of the sensor in both in vitro and ex vivo simulated gastric models, quantified its key behaviors in the GI tract by using computational modeling, and validated its functionality in awake and ambulating swine. Our piezoelectric devices can safely sense mechanical variations and harvest mechanical energy inside the gastrointestinal tract for diagnosing and treating motility disorders and for monitoring ingestion in bariatric applications.
System and method for an ingestible physiological monitor
In accordance with some non-limiting examples of the disclosed subject matter, an ingestible system configured to acquire physiological information from an interior of a subject is provided, comprising a substrate and at least one physiological sensor. The at least one “physiological sensor can be coupled to the substrate and configured to capture physiological data from at least one of an internal area or an orientation in a digestive tract of the subject. The system can include a controller coupled to the substrate and configured to receive the physiological data and prepare the physiological data for one of transmission from the subject or analysis of the physiological data. The substrate, including the at least one physiological sensor and the controller coupled thereto can be configured to self-orient within the digestive tract of the subject, during ingestion of the system by the subject.
USE OF A CHEMIRESISTOR SENSOR FOR IMPROVING HEALTH
The present invention provides methods for profiling the microbiome of a subject from a sample obtained from the subject using a Scent Reader/Recorder which detects and records the scent in the headspace of the sample and generates a pattern of sensor signals that can be analyzed using machine learning techniques. The invention further provides methods for detecting changes in the microbiome profile of a subject, and methods for providing health and nutritional recommendations to subjects.
Systems approach to disease state and health assessment
Methods, systems, and apparatus for assessing a state of an epilepsy disease or a comorbidity thereof are provided. The methods comprise receiving at least one autonomic index, neurologic index, stress marker index, psychiatric index, endocrine index, adverse effect of therapy index, physical fitness index, or quality of life index of a patient; comparing the at least one index to at least one reference value; and assessing a state of an epilepsy disease or a body system of the patient based on the comparison. A computer readable program storage device encoded with instructions that, when executed by a computer, perform the method described above is also provided. A medical device system capable of implementing the method described above is also provided.
System and method for patient monitoring of gastrointestinal function using automated stool classifications
A method of data collection of stool data via a mobile device operable to enable monitoring of gastrointestinal function. A related method of long-term monitoring of patient gastrointestinal function, using one or more signal processing tools (e.g. machine learning algorithms) for automatically interpreting patient stool data, including real-time patient-assessments, in order to detect an adverse clinical event from patient stool data. A system for facilitating real-time monitoring the gastrointestinal function, the system comprising: a camera on a mobile device, a user interface that facilitates self-monitoring of stool characteristics, so as to create health-monitoring data; mobile device storage, server storage, and remote storage (with at least one communication link between them) for storing some or all of the health-monitoring data; and a processor for interpreting such health-monitoring data for clinical or other health-monitoring application.